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Abstract
Background: High-density lipoprotein (HDL) is a major
plasma lipoprotein directly associated with cholester-
ol metabolism. The ATP binding cassette transporter
1 gene (ABCA1) is one of the major genes modulating
plasma levels of HDL-cholesterol (HDL-C). Rare alleles
of ABCA1 associated with extreme HDL-C concentra-
tions have not been previously investigated in the
Chinese.
Methods: Blood samples were collected from 470
subjects whose HDL-C concentrations were within the
top 5% of the distribution, 335 subjects in the lowest
5%, and 220 within the range 5%–95%. First, we
sequenced all exons of the ABCA1 gene from 50 sub-
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jects from the group with extremely high HDL-C, and
50 from the group with extremely low HDL-C con-
centrations. Next, in the remaining subjects, we
genotyped the non-synonymous variants identified
exclusively with either extreme group.
Results: Four novel non-synonymous alleles were
identified; all were rare. Alleles c.3029C)T
(p.Ala1010Val) and c.5399A)G (p.Asn1800Ser) were
found exclusively in the low group, c.2031C)A
(p.Asp677Glu) and c.2660G)T (p.Cys887Phe) exclu-
sively in the high group.
Conclusions: Our results show that some rare alleles
of ABCA1 are associated with marked phenotypes,
supporting the ‘‘rare-variant common-disease’’
hypothesis. Certain alleles also provide tools for iden-
tifying individuals at high risk of dyslipidaemia, allow-
ing for early therapeutic intervention.
Clin Chem Lab Med 2009;47:1239–45.
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Introduction
High-density lipoprotein (HDL) is one of the major
plasma lipoproteins directly associated with choles-
terol metabolism. Low concentrations of HDL-choles-
terol (HDL-C) are a strong and independent risk factor
for coronary heart disease (1). About 50% of the
variation in plasma level HDL-C is believed to be
genetically determined (2, 3). ATP binding cassette
transporter 1 gene (ABCA1, Genbank ID NM_005502,
alias: ABC1; CERP; ABC-1) is one of the major genes
modulating plasma HDL-C concentrations, and under-
lies two genetic diseases with low HDL-C: Tangier
disease (MIM 205400) and familial HDL deficiency
(MIM 604091) (4). ABCA1 codes for cholesterol efflux
regulatory protein (CERP, UniProtKB/Swiss-Prot
O95477). This protein mediates the intracellular cho-
lesterol pump, thereby transporting cellular choles-
terol to the plasma membrane and incorporating it
into plasma HDL particles.
The ‘‘common-variant common-disease’’ is the
accepted hypothesis for the genetic contribution to
common disease. Recently, several studies have
shown that rare alleles also contribute to common
diseases, and may have stronger phenotypic effects
than common alleles (5–10). This has prompted
efforts to identify rare alleles in common diseases.
The importance of studying rare alleles lies not only
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in identifying individuals at high risk to allow for early
intervention, but also in understanding disease mech-
anisms and gene function. Variations in ABCA1 from
white and black Americans, and Danish individuals
have been reported (5, 6). Wang and co-workers (11)
screened for ABCA1 mutations in a Caucasian family
with Tangier disease, aboriginal Canadians of Oji-
Cree and Inuit origin with familial HDL deficiency and
a subgroup of 37 Chinese normolipidaemic subjects
selected from 223 subjects. They reported three
common non-synonymous variants of ABCA1:
p.Val825Ile, p.Ile883Met and p.Arg1587Lys (originally
reported as V/I765, I/M823 and R/K1527) among the
Chinese subjects (11). However, rare alleles of the
gene associated with extreme HDL-C concentrations
among the Han Chinese have not been previously
investigated. It is not known whether there are pop-
ulation-specific alleles bearing strong phenotypic
effects. In an attempt to further test the ‘‘rare-variant
common-disease’’ hypothesis and study whether
there are some rare alleles that may have strong
phenotypic effects among the Han Chinese, we stud-
ied subjects showing extreme HDL-C concentrations
and their associated rare alleles.
Materials and methods
Study subjects
A total of 1025 subjects were recruited from the general pop-
ulation and individuals who underwent health checks from
April to November 2008 at laboratories in two centres (the
Third Affiliated Hospital of Sun Yat-Sen University and
Dongguan People’s Hospital) in Guangdong Province,
Southern China. All subjects were of Han Chinese ethnicity.
The distribution of HDL-C concentrations among the Han
Chinese and selection for genotyping were based on distri-
bution data for Japanese subjects recommended by Daiichi
Pure Chemicals (male 1.41"0.33 mmol/L, female 1.58"
0.32 mmol/L; http://www.sekisuimedical.jp/). These ranges
were adopted at the two centres used in this study. The
study group included 470 subjects, in whom HDL-C concen-
trations were in the top 5% of the distribution (extremely
high group); 335 in the lowest 5% (extremely low group); and
220 subjects in which HDL-C was within the 5% and 95%
limits (middle-range group). Individuals with diseases or
conditions that may affect plasma HDL-C, such as diabetes
mellitus, dysthyroidism, liver dysfunction, and pregnancy,
were excluded. All subjects gave informed consent. The
study was conducted in accordance with the Declaration of
Helsinki and was approved by the University Ethics
Committee.
HDL-C measurement
Following a 12-h fast, blood was collected in tubes that
promote coagulation. Blood samples were centrifuged at
1800 g for 10 min and the supernatant carefully separated.
HDL-C was measured using a homogenous method (12), the
Cholestest N HDL kit (Daiichi Pure Chemicals, Kyoto, Japan)
with a Hitachi autoanalyzer (Hitachi, Tokyo, Japan) according
to the manufacturer’s instructions. Cholestest N calibrator
(Daiichi Pure Chemicals) was used to calibrate the assay
necessary. Liquid Assayed Multiqual (BioRad, Irvine, CA,
USA) was used for quality control to monitor the precision of
the HDL-C procedure. The quality control value for HDL-C
for Level 2 was 1.39"0.15 mmol/L, and for Level 3, 1.97"
0.15 mmol/L.
Detection of rare alleles of ABCA1
Direct sequencing of all exons in 50 subjects in the high and
50 subjects in the low HDL-C groups As phenotype-asso-
ciated rare alleles are more likely to be harboured in extreme
phenotypes, we first explored rare alleles in the low and high
HDL-C groups. Fifty randomly selected subjects (31 males
and 19 females, age 55"18 years) in the low HDL-C group
and 50 subjects (28 males and 22 females, age 46"19 years)
in the high HDL-C group were first screened for ABCA1 var-
iation. Genomic DNA was extracted from peripheral blood
cells with Tiangen DNA blood Mini kits (Tiangen, Beijing,
China) according to the manufacturer’s instructions. Primers
were designed for all the exons and intron-exon boundaries,
with 100–200 bp extensions into intronic regions. PCR prod-
ucts were sequenced in both directions using the ABI
Sequence Analyzer 3730=L (Applied Biosystems, Foster
City, CA, USA). Results were compared with sequences
retrieved from the UCSC Genome Browser (http://genome.
ucsc.edu). Standard nomenclature, as described by den Dun-
nen and Antonarakis (www.hgvs.org/mutnomen/) (13), was
used for description of DNA sequence variation, with q1 cor-
responding to the A of the ATG translation initiation codon
of the GenBank mRNA sequence NM_005502.2. Genomic
DNA (gDNA) numbering is also provided with the first nucle-
otide of GenBank reference sequence NG_007981 as q1.
TaqMan-based genotyping assays in the rest of the
assembly Six rare non-synonymous variants, not shared in
both groups, were identified using direct sequencing as
described above, using high and low HDL-C groups. The var-
iants were then tested for in the remaining individuals with
extreme HDL-C (high and low groups) using the TaqMan-
based genotyping assay with the ABI 7500 real-time PCR
System (Applied Biosystems). In order to explore the phe-
notypic effects and further confirm the rarity of these alleles,
we also tested for these same alleles in the subjects with
HDL-C in the middle-range. Primer Express 2.0 (Applied Bio-
systems) was used to design primers and probes (listed in
Table 1). Premix Ex TaqTM kit (TaKaRa, Otsu, Shiga, Japan)
was used in the genotyping assay. The reaction mix con-
tained 10 mL premix, 10 mM primers, 10 mM probes, 0.4 mL
ROX reference dye, and 10 ng DNA template, in a total vol-
ume of 20 mL. Amplification was carried out with one 10 s
cycle at 958C, 50, 5 s cycles at 958C and maintenance at 608C
for 34 s. The SDS v1.2= System Software (Applied Biosys-
tems) was used to analyse the results. Sample genotypes
confirmed by direct sequencing were used as positive con-
trols and samples with no DNA as negative controls in each
plate.
Cross-species alignment of ABCA1 cDNA
and protein sequences
The CLUSTAL X (1.81) program (http://www.clustal.org/) was
used to compare the human ABCA1 cDNA sequence
(NM_005502) with nucleotide sequences of the mouse
(Mus musculus) (NM_013454.3), rat (Rattus norvegicus)
(NM_178095.2) and chicken (Gallus gallus) (NM_204145.1).
The same program was used to compare amino acid
sequences between these species (human UniProtKB/Swiss-
Prot O95477; mouse P41233; rat Q80ZB2; and chicken
Q8UVV4).
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Table 1 Primers and probes used in the TaqMan-based genotyping assay.
Variations Substitutions Primer/probe Sequence 59™39
p.Arg496Trp c.1486C)T Primers-F/R TCCAGTCCAGTAATGGTTCTGTGTA/CCTGTGTTAGGCTTGAGGGATAGT
Probe-C FAM-CTAACCAGGCAATCCGGACCATATCTC-TAMRA
Probe-T HEX-CTAACCAGGCAATCTGGACCATATCTCG-TAMRA
p.Asp677Glu c.2031C)A Primers-F/R TCACAAGAAGAGGAATGAGGCTACT/CTTTCTCCCCTTGTCCTTCCTT
Probe-C FAM-ATGCTGTTGTCCAGGCCCATGAT-TAMRA
Probe-A HEX-ATGCTGTTTTCCAGGCCCATGATC-TAMRA
p.Cys887Phe c.2660G)T Primers-F/R GTGCTTTCTGTGGGTTCATTTCT/ACCTTCATCCCATCTCGGTAGA
Probe-G FAM-TCCTGTCACAGTCTGCATGGAGGAG-TAMRA
Probe-T HEX-CCTGTCACAGTCTTCATGGAGGAGGA-TAMRA
p.Ala1010Val c.3029C)T Primers-F/R TTTTGCTTTTCAGCTTGCTTGA/AGGCTGACTGTCGAAGAACACAT
Probe-C FAM-TCCATCTCCGCCTTCACGTGC-TAMRA
Probe-T HEX-CTGCTCCATCTCCACCTTCACGTG-TAMRA
p.Val1096Ile c.3286G)A Primers-F/R GAGGAGCCCACACAGCACA/TCCAGTGCTTACCCCTGCTAAT
Probe-G FAM-CCCCAGGACGTCCGCTTCATC-TAMRA
Probe-A HEX-CCCAGGATGTCCGCTTCATCCA-TAMRA
p.Asn1800Ser c.5399A)G Primers-F/R ATGAATGACACCCGTTTCTTCTC/ATTGCCTGGTTTTTCACCATGT
Probe-A FAM-AATAATATCAATGATATCCTGAAGT-MGB
Probe-G HEX-ATAATATCAGTGATATCCTGAAG-MGB
Table 2 Plasma concentrations of HDL-C, gender and age of the study population.
Low HDL-C High HDL-C Middle-range HDL-C
Male Female Male Female Male Female
HDL-C, mmol/L 0.60"0.17 0.72"0.18 2.25"0.26 2.39"0.23 1.39"0.14 1.64"0.15
Age, years 53"18 52"19 47"16 54"14 51"15 47"12
Number 192 143 290 180 91 129
Total number 335 470 220
Topological model of wild-type and mutant
proteins
HMMTOP (14), TMHMM (15), TMpred (16), Tmap (17), DAS
(18), Phobius (19), TOPpred (20) and SOSUI (21) softwares
were used to model the transmembrane topology of the
wild-type and mutant CERP proteins found to be exclusively
associated with extreme HDL-C concentrations.
Results
HDL-C levels
A total of 335 subjects with extremely low HDL-C, 470
with extremely high HDL-C concentrations and 220
with middle-range HDL-C were recruited. Details of
HDL-C concentrations, gender and age of the subjects
are shown in Table 2.
Rare alleles identified and their association
with HDL-C levels
Results of direct sequencing in the 50 high and 50
low HDL-C subjects A total of 21 variants were dis-
covered using direct sequencing of the randomly
selected subjects in the two groups with extreme
HDL-C concentrations (Table 3), 17 coding and
four non-coding. Among the coding variants, 11 were
non-synonymous and six synonymous with respect to
amino acid sequence; five were novel. Six of the 11
non-synonymous variants were identified exclusively
in either the low or the high HDL-C groups, the other
five were shared by these two groups (Table 3). The
six exclusive alleles were rare in the subjects who
were sequenced (Table 3).
Results of the TaqMan-based genotyping assays and
comparisons between the different HDL-C groups
Genotyping of the six exclusive alleles in the remain-
ing subjects comprising the groups with high and low
HDL-C, and the subjects with HDL-C in the middle
range (middle-range HDL-C group), further confirmed
the rarity of the six alleles (Table 4). The c.1486C)T
(p.Arg496Trp) allele initially identified in the low
HDL-C group only, was also found in the middle
HDL-C group. Allele c.3286G)A (p.Val1096Ile), initial-
ly identified only in the high HDL-C group, was alsofj
found in the middle HDL-C group. Therefore, the
alleles associated exclusively with high HDL-C
were c.2031C)A (p.Asp677Glu) and c.2660G)T
(p.Cys887Phe). The alleles associated exclusively with
low HDL-C were c.3029C)T (p.Ala1010Val) and
c.5399A)G (p.Asn1800Ser) (Table 4, Figure 1). These
four exclusive alleles are all novel (Table 4).
Across-species comparisons
Alleles c.2031C)A (p.Asp677Glu), c.2660G)T
(p.Cys887Phe) and c.5399A)G (p.Asn1800Ser)
occurred in the highly conserved nucleotide and
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Table 3 Variants of ABCA1 identified by direct sequencing.
Gene region Nucleotide change Amino acid References or No. of subjects
dbSNP ID
Low (ns50) High (ns50)
Ha Qb Ha Qb
Untranslated exonic region
Exon 2 g.24399_24400insG – rs1799777 11 0 10 0
Exon 2 g.24459G)C – rs1800978 11 0 10 0
Exon 50 g.146152A)G – rs4149341 27 2 24 4
Exon 50 g.146738_146740delGTT – rs41474449 23 0 20 0
Translated exonic region
Non-synonymous
Exon 7 c.656G)A p.Arg219Lys rs2230806 24 7 39 1
Exon 12 c.1486C)T p.Arg496Trp Ref. (5) 1 0 0 0
Exon 15 c.2031C)A p.Asp677Glu Novel 0 0 1 0
Exon 16 c.2311G)A p.Val771Met rs2066718 5 0 2 0
Exon 17 c.2473G)A p.Val825Ile rs2066715 25 7 37 4
Exon 18 c.2649G)A p.Met883Ile rs2066714 19 7 19 3
Exon 19 c.2660G)T p.Cys887Phe Novel 0 0 1 0
Exon 21 c.3029C)T p.Ala1010Val Novel 1 0 0 0
Exon 23 c.3286G)A p.Val1096Ile rs13306073 0 0 1 0
Exon 35 c.4760G)A p.Arg1587Lys rs2230808 24 6 31 4
Exon 40 c.5399A)G p.Asn1800Ser Novel 1 0 0 0
Synonymous
Exon 6 c.474G)A p.Leu158 rs2230805 13 16 13 21
Exon 9 c.936C)T p.Pro312 rs2274873 1 0 6 0
Exon 9 c.948G)A p.Gly316 rs2246841 3 0 2 0
Exon 15 c.2040A)C p.Ile680 rs2853579 19 7 20 3
Exon 16 c.2148C)T p.Ser716 Novel 0 0 1 0
Exon 31 c.4281G)A p.Thr1427 rs2066716 22 8 22 7
aH, heterozygote of the minor alleles; bQ, homozygote of the minor allele. Rare variants associated with extreme HDL-C
concentrations are indicated in bold font.
Table 4 Rare alleles identified in the whole study population.
Allele HDL-C, mmol/L No. of subjectsa Domain
(Male/female)
In this In the whole
group assembly
(ns1025)
Low HDL-C group ns335
c.3029C)T (p.Ala1010Val) 0.74/–b 1 1 1st ABCc
c.5399A)G (p.Asn1800Ser) –b/0.74 1 1 5th intracellular loop
High HDL-C group ns470
c.2031C)A (p.Asp677Glu) –b/2.13 1 1 1st intracellular loop
c.2660G)T (p.Cys887Phe) 2.09/2.27 2 2 H7d
Low HDL-C groupqmiddle group ns555
c.1486C)T (p.Arg496Trp) –b/1.03"0.79 2 2 Extracellular N-term loop
High HDL-C groupqmiddle group ns690
c.3286G)A (p.Val1096Ile) 2.14"0.06/2.23"0.21 6 6 1st ABCc
Other combinations of HDL-C groupse
No rare variation
aAll subjects were heterozygotes of the minor allele; bno rare variation was found with respect to gender of the subject; cABC,
ATP-hydrolysing domain; dH7, the 7th hydrophobic segment; eother combinations of HDL-C groups includes the
‘‘high’’q‘‘low’’ and ‘‘high’’q‘‘lowqmiddle’’ groups.
amino acid sequences in all four species studied.
Nucleotide C in c.3029C)T (p.Ala1010Val) was
conserved in humans, mice and rats, but not in chick-
ens (Figure 2).
Transmembrane topology of wild-type and mutant
proteins
Gene ABCA1 contains 50 exons, translation of CERP
being initiated in exon 2, terminating in exon 50
(http://genome.ucsc.edu). The wild-type protein has
two membrane-integral domains, each containing six
membrane-spanning a-helices and two ATP-hydrolys-
ing domains (22). Transmembrane topology simula-
tion showed no predictable differences between
wild-type and mutant proteins. However, all the exclu-
sively-associated alleles were located in the function-
ally important regions, implying potential modes of
action of these alleles. These are p.Asp677Glu in the
first intracellular loop; p.Cys887Phe in the seventh
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Figure 1 Partial sequencing results of the forward strand of the four rare alleles.
Arrows denote the alleles. (A) c.2031C)A; (B) c.2660G)T; (C) c.3029C)T; (D) c.5399A)G.
hydrophobic segment; p.Ala1010Val in the first ATP-
hydrolysing domain, known to be necessary for trans-
porter activity (23), and p.Asn1800Ser in the fifth
intracellular loop.
Discussion
The ABCA1 gene belongs to the large ABC membrane
transporter superfamily. The encoded proteins
transport various molecules, including metabolites,
cholesterol, steroids and drugs across intra- and
extra-cellular membranes. In humans, there are 49
paralogues of the superfamily, and 13 of these have
been identified as being responsible for Mendelian
diseases, including cystic fibrosis (MIM 219700),
Startgardt disease (MIM 600110), Dubin-Johnson syn-
drome (MIM 237500), progressive familial intrahepa-
tic cholestasis-3 (MIM 602347), X-linked sideroblastic
anaemia and ataxia (MIM 301310). The ABCA1 encod-
ed protein, CERP, modulates cholesterol metabolism
by mediating the ‘‘reverse transport’’ of cholesterol
by pumping intracellular cholesterol to the plasma
membrane and its subsequent incorporation into
plasma HDL particles. The liver is the major organ
where cholesterol is degraded and secreted. ABCA1,
therefore, plays a crucial role in regulating plasma
cholesterol concentrations. This has been clearly
demonstrated in Tangier disease (MIM 205400) and
familial HDL deficiency (MIM 604091). The classical
phenotypes of Tangier disease are the near absence
of HDL-C in plasma and clinical symptoms caused
by intracellular cholesterol accumulation including
enlarged yellow tonsils, splenohepatomegaly, and
peripheral neuropathy (24). In familial HDL deficiency,
plasma HDL-C is greatly reduced, accompanied by a
higher incidence of premature coronary heart disease
and atherosclerosis (25).
Plasma HDL-C concentrations are determined by
both genetic and environmental factors. Inheritance is
generally considered to be polygenic in the majority
of subjects, but, as stated above, there are also
Mendelian conditions associated with extreme HDL-C
concentrations like Tangier disease and familial HDL
deficiency. Cohen and colleagues demonstrated that
rare alleles of ABCA1 are associated with extreme
HDL-C concentrations in Caucasians and African
Americans in the US (5). This was confirmed by a large
population-based study of subjects from Denmark
that showed that both rare alleles and common vari-
ants also contribute to HDL-C concentrations in the
general population (6). These and other recent studies
(5–10) demonstrate that rare alleles not only contrib-
ute to common diseases, but can also exert stronger
phenotypic effects than common variants. To priori-
tise our efforts on the strong phenotype-bearing alle-
les, the present study was restricted to identify rare
alleles. Our results show that alleles of c.3029C)T
(p.Ala1010Val) and c.5399A)G (p.Asn1800Ser) are
exclusively associated with low HDL-C, c.2031C)A
(p.Asp677Glu) and c.2660G)T (p.Cys887Phe) with
high HDL-C in Han Chinese. These alleles were rare,
but the frequencies obtained from the whole assem-
bly may not be representative of true population fre-
quencies. This is because there were more subjects
tested in the extreme HDL-C groups than in the mid-
dle-range group, and the ratio of males and females
was not equivalent. The three common non-synony-
mous variants reported by Wang et al. (11) were also
detected in our subjects, but none was associated
exclusively with extreme HDL-C concentrations.
These results not only support the ‘‘rare-variant com-
mon-disease’’ hypothesis, but also demonstrate that
rare alleles can have strong phenotypic effects in dif-
ferent populations. The four extreme phenotype-asso-
ciated alleles are novel. More importantly from a
clinical point of view, our results provide a novel tool
for identifying individuals at high risk, with the poten-
tial for early intervention. In the present study, allele
c.1486C)T (p.Arg496Trp), previously shown to be
associated with high HDL-C in American subjects, was
identified in Han Chinese subjects from the groups
with extremely low- and middle-range HDL-C concen-
trations. The reason for this discrepancy is currently
unknown and further studies are needed to address
this question.
The ABCA1 gene is located on 9q31 and consists of
50 exons. Its protein product is translated from within
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Figure 2 Multiple sequence alignment of ABCA1 across
species.
The CLUSTAL X (1.81) program was used to align the cDNA
and protein sequences between species. The nucleotides
and amino acids corresponding to the four rare variants are
framed. (A) c.2031C)A (p.Asp677Glu); (B) c.2660G)T
(p.Cys887Phe); (C) c.3029C)T (p.Ala1010Val); (D) c.5399A)G
(p.Asn1800Ser). Identical bases and amino acids in the four
species are denoted with asterisks.
exon 2 and terminates in the part of exon 50 that con-
sists of 2261 amino acids (http://www.uniprot.org/
uniprot/). Topological models of wild-type and mutant
proteins show that all the extreme phenotype-asso-
ciated mutant sites occur in functionally important
regions. None occurred in the transmembrane sec-
tion, consistent with previous findings in a Danish
population (6). Rare alleles are important, although
the present study demonstrates that not all rare
alleles have significant phenotypic effects. In the
present study, alleles c.1486C)T (p.Arg496Trp) and
c.3286G)A (p.Val1096Ile) were not associated with
any phenotypic changes. Some rare alleles, even
coding variations, may therefore be neutral, as also
found in the Danish population (6).
Plasma HDL-C concentrations and studies of the
genetic contributions underlie that it serves as a good
example to show that most clinical conditions can be
caused by mutations in more than one gene, as well
as by a whole spectrum of frequencies of alleles that
may be common or rare within each gene. Some rare
alleles are more often associated with extreme phe-
notypes. Re-sequencing and deep-sequencing efforts
are therefore important for revealing these rare but
significant alleles. This is important not only for iden-
tification of individuals at high risk who may benefit
from early intervention, but also for our basic under-
standing of mechanisms of disease.
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